{"file_history": "{\"/home/user/Documents/WorkingDir/JUMPDiscovery_attempt_3/analyze_notch_morphology.py\": [\"#!/usr/bin/env python3\\n\\\"\\\"\\\"\\nComprehensive morphological analysis of NOTCH knockout cells\\n\\\"\\\"\\\"\\n\\nimport numpy as np\\nimport pandas as pd\\nimport matplotlib.pyplot as plt\\nimport seaborn as sns\\nfrom pathlib import Path\\nimport tifffile\\nfrom scipy import ndimage\\nfrom skimage import filters, measure, morphology, segmentation\\nfrom skimage.feature import peak_local_max\\nimport warnings\\nwarnings.filterwarnings('ignore')\\n\\n# Set style\\nsns.set_style('whitegrid')\\nplt.rcParams['figure.dpi'] = 150\\n\\ndef load_images(base_dir, condition, site=1):\\n    \\\"\\\"\\\"Load all channels for a given condition\\\"\\\"\\\"\\n    images = {}\\n    channels = ['DNA', 'ER', 'AGP', 'Mito', 'RNA']\\n    \\n    for channel in channels:\\n        pattern = f\\\"*site{site}_{channel}.tiff\\\"\\n        files = list(Path(base_dir).glob(pattern))\\n        if files:\\n            images[channel] = tifffile.imread(files[0])\\n    \\n    return images\\n\\ndef segment_nuclei(dna_image, min_size=100):\\n    \\\"\\\"\\\"Segment nuclei from DNA channel\\\"\\\"\\\"\\n    # Gaussian smoothing\\n    smoothed = filters.gaussian(dna_image, sigma=2)\\n    \\n    # Otsu thresholding\\n    thresh = filters.threshold_otsu(smoothed)\\n    binary = smoothed > thresh\\n    \\n    # Remove small objects\\n    cleaned = morphology.remove_small_objects(binary, min_size=min_size)\\n    \\n    # Fill holes\\n    filled = ndimage.binary_fill_holes(cleaned)\\n    \\n    # Distance transform for watershed\\n    distance = ndimage.distance_transform_edt(filled)\\n    \\n    # Find peaks\\n    local_max = peak_local_max(distance, min_distance=20, labels=filled)\\n    markers = np.zeros_like(distance, dtype=bool)\\n    markers[tuple(local_max.T)] = True\\n    markers = ndimage.label(markers)[0]\\n    \\n    # Watershed segmentation\\n    labels = segmentation.watershed(-distance, markers, mask=filled)\\n    \\n    return labels\\n\\ndef segment_cells(dna_image, agp_image, min_size=200):\\n    \\\"\\\"\\\"Segment cells using DNA and AGP channels\\\"\\\"\\\"\\n    # Combine DNA and AGP for cell boundary detection\\n    combined = filters.gaussian(dna_image, sigma=2) + filters.gaussian(agp_image, sigma=2)\\n    \\n    # Threshold\\n    thresh = filters.threshold_otsu(combined)\\n    binary = combined > thresh\\n    \\n    # Clean up\\n    cleaned = morphology.remove_small_objects(binary, min_size=min_size)\\n    filled = ndimage.binary_fill_holes(cleaned)\\n    \\n    # Label\\n    labels = measure.label(filled)\\n    \\n    return labels\\n\\ndef measure_cell_features(images, nuclei_labels, cell_labels):\\n    \\\"\\\"\\\"Measure comprehensive morphological features\\\"\\\"\\\"\\n    features = []\\n    \\n    # Get region properties\\n    nuclei_props = measure.regionprops(nuclei_labels, intensity_image=images['DNA'])\\n    cell_props = measure.regionprops(cell_labels, intensity_image=images['DNA'])\\n    \\n    # Match nuclei to cells\\n    for nuc_prop in nuclei_props:\\n        nuc_centroid = nuc_prop.centroid\\n        nuc_y, nuc_x = int(nuc_centroid[0]), int(nuc_centroid[1])\\n        \\n        # Find corresponding cell\\n        if 0 <= nuc_y < cell_labels.shape[0] and 0 <= nuc_x < cell_labels.shape[1]:\\n            cell_label = cell_labels[nuc_y, nuc_x]\\n            \\n            if cell_label > 0:\\n                # Get cell properties\\n                cell_prop = [p for p in cell_props if p.label == cell_label]\\n                if not cell_prop:\\n                    continue\\n                cell_prop = cell_prop[0]\\n                \\n                # Create cell and nucleus masks\\n                cell_mask = cell_labels == cell_label\\n                nuc_mask = nuclei_labels == nuc_prop.label\\n                cyto_mask = cell_mask & ~nuc_mask\\n                \\n                # Basic morphology\\n                feature = {\\n                    'nucleus_area': nuc_prop.area,\\n                    'cell_area': cell_prop.area,\\n                    'cytoplasm_area': cyto_mask.sum(),\\n                    'nucleus_cell_ratio': nuc_prop.area / cell_prop.area if cell_prop.area > 0 else 0,\\n                    \\n                    # Shape features\\n                    'nucleus_eccentricity': nuc_prop.eccentricity,\\n                    'nucleus_solidity': nuc_prop.solidity,\\n                    'nucleus_extent': nuc_prop.extent,\\n                    'cell_eccentricity': cell_prop.eccentricity,\\n                    'cell_solidity': cell_prop.solidity,\\n                    'cell_extent': cell_prop.extent,\\n                    'cell_perimeter': cell_prop.perimeter,\\n                    'cell_compactness': (4 * np.pi * cell_prop.area) / (cell_prop.perimeter ** 2) if cell_prop.perimeter > 0 else 0,\\n                    \\n                    # Intensity features - DNA\\n                    'nucleus_dna_mean': nuc_prop.mean_intensity,\\n                    'nucleus_dna_std': np.std(images['DNA'][nuc_mask]),\\n                    'nucleus_dna_max': np.max(images['DNA'][nuc_mask]),\\n                    \\n                    # Intensity features - ER\\n                    'cell_er_mean': np.mean(images['ER'][cell_mask]),\\n                    'cell_er_std': np.std(images['ER'][cell_mask]),\\n                    'cyto_er_mean': np.mean(images['ER'][cyto_mask]) if cyto_mask.sum() > 0 else 0,\\n                    \\n                    # Intensity features - Mitochondria\\n                    'cell_mito_mean': np.mean(images['Mito'][cell_mask]),\\n                    'cell_mito_std': np.std(images['Mito'][cell_mask]),\\n                    'cyto_mito_mean': np.mean(images['Mito'][cyto_mask]) if cyto_mask.sum() > 0 else 0,\\n                    \\n                    # Intensity features - AGP (Actin/Golgi)\\n                    'cell_agp_mean': np.mean(images['AGP'][cell_mask]),\\n                    'cell_agp_std': np.std(images['AGP'][cell_mask]),\\n                    'cyto_agp_mean': np.mean(images['AGP'][cyto_mask]) if cyto_mask.sum() > 0 else 0,\\n                    \\n                    # Intensity features - RNA\\n                    'cell_rna_mean': np.mean(images['RNA'][cell_mask]),\\n                    'cell_rna_std': np.std(images['RNA'][cell_mask]),\\n                    'cyto_rna_mean': np.mean(images['RNA'][cyto_mask]) if cyto_mask.sum() > 0 else 0,\\n                    \\n                    # Texture features (granularity)\\n                    'nucleus_dna_granularity': np.std(ndimage.gaussian_filter(images['DNA'][nuc_mask].astype(float), sigma=1)),\\n                    'mito_granularity': np.std(ndimage.gaussian_filter(images['Mito'][cell_mask].astype(float), sigma=1)),\\n                }\\n                \\n                features.append(feature)\\n    \\n    return pd.DataFrame(features)\\n\\ndef analyze_condition(base_dir, condition_name):\\n    \\\"\\\"\\\"Analyze all sites for a condition\\\"\\\"\\\"\\n    print(f\\\"\\\\nAnalyzing {condition_name}...\\\")\\n    \\n    all_features = []\\n    \\n    for site in [1, 2, 3]:\\n        try:\\n            # Load images\\n            images = load_images(base_dir, condition_name, site=site)\\n            \\n            if len(images) < 5:\\n                print(f\\\"  Site {site}: Missing channels, skipping\\\")\\n                continue\\n            \\n            # Segment\\n            nuclei_labels = segment_nuclei(images['DNA'])\\n            cell_labels = segment_cells(images['DNA'], images['AGP'])\\n            \\n            n_nuclei = nuclei_labels.max()\\n            n_cells = cell_labels.max()\\n            print(f\\\"  Site {site}: {n_nuclei} nuclei, {n_cells} cells\\\")\\n            \\n            # Measure features\\n            features = measure_cell_features(images, nuclei_labels, cell_labels)\\n            features['site'] = site\\n            features['condition'] = condition_name\\n            \\n            all_features.append(features)\\n            \\n        except Exception as e:\\n            print(f\\\"  Site {site}: Error - {e}\\\")\\n            continue\\n    \\n    if all_features:\\n        return pd.concat(all_features, ignore_index=True)\\n    else:\\n        return pd.DataFrame()\\n\\ndef main():\\n    \\\"\\\"\\\"Main analysis pipeline\\\"\\\"\\\"\\n    print(\\\"=\\\" * 80)\\n    print(\\\"NOTCH RECEPTOR KNOCKOUT MORPHOLOGICAL ANALYSIS\\\")\\n    print(\\\"=\\\" * 80)\\n    \\n    # Define conditions\\n    conditions = {\\n        'NOTCH1_KO': 'images/NOTCH1_KO',\\n        'NOTCH2_KO': 'images/NOTCH2_KO',\\n        'NOTCH3_KO': 'images/NOTCH3_KO',\\n        'NegCon': 'images/negcon'\\n    }\\n    \\n    # Analyze each condition\\n    all_data = []\\n    for condition_name, base_dir in conditions.items():\\n        df = analyze_condition(base_dir, condition_name)\\n        if not df.empty:\\n            all_data.append(df)\\n    \\n    # Combine all data\\n    if not all_data:\\n        print(\\\"No data collected!\\\")\\n        return\\n    \\n    combined_df = pd.concat(all_data, ignore_index=True)\\n    \\n    # Save raw data\\n    combined_df.to_csv('notch_morphology_features.csv', index=False)\\n    print(f\\\"\\\\nTotal cells analyzed: {len(combined_df)}\\\")\\n    print(f\\\"  NOTCH1_KO: {len(combined_df[combined_df['condition'] == 'NOTCH1_KO'])}\\\")\\n    print(f\\\"  NOTCH2_KO: {len(combined_df[combined_df['condition'] == 'NOTCH2_KO'])}\\\")\\n    print(f\\\"  NOTCH3_KO: {len(combined_df[combined_df['condition'] == 'NOTCH3_KO'])}\\\")\\n    print(f\\\"  NegCon: {len(combined_df[combined_df['condition'] == 'NegCon'])}\\\")\\n    \\n    # Statistical summary\\n    print(\\\"\\\\n\\\" + \\\"=\\\" * 80)\\n    print(\\\"STATISTICAL SUMMARY\\\")\\n    print(\\\"=\\\" * 80)\\n    \\n    # Key features to compare\\n    key_features = [\\n        'nucleus_area', 'cell_area', 'nucleus_cell_ratio',\\n        'cell_eccentricity', 'cell_compactness',\\n        'nucleus_dna_mean', 'cell_er_mean', 'cell_mito_mean',\\n        'cell_agp_mean', 'cell_rna_mean', 'mito_granularity'\\n    ]\\n    \\n    summary = combined_df.groupby('condition')[key_features].agg(['mean', 'std'])\\n    print(summary)\\n    \\n    # Create visualizations\\n    print(\\\"\\\\n\\\" + \\\"=\\\" * 80)\\n    print(\\\"CREATING VISUALIZATIONS\\\")\\n    print(\\\"=\\\" * 80)\\n    \\n    # 1. Distribution plots for key features\\n    fig, axes = plt.subplots(3, 4, figsize=(20, 15))\\n    axes = axes.flatten()\\n    \\n    plot_features = [\\n        'nucleus_area', 'cell_area', 'nucleus_cell_ratio', 'cell_compactness',\\n        'nucleus_dna_mean', 'cell_er_mean', 'cell_mito_mean', 'cell_agp_mean',\\n        'cell_rna_mean', 'mito_granularity', 'nucleus_dna_granularity', 'cell_eccentricity'\\n    ]\\n    \\n    for idx, feature in enumerate(plot_features):\\n        ax = axes[idx]\\n        for condition in ['NegCon', 'NOTCH1_KO', 'NOTCH2_KO', 'NOTCH3_KO']:\\n            data = combined_df[combined_df['condition'] == condition][feature]\\n            if len(data) > 0:\\n                ax.hist(data, alpha=0.5, label=condition, bins=30, density=True)\\n        \\n        ax.set_xlabel(feature.replace('_', ' ').title())\\n        ax.set_ylabel('Density')\\n        ax.legend(fontsize=8)\\n        ax.grid(True, alpha=0.3)\\n    \\n    plt.tight_layout()\\n    plt.savefig('notch_feature_distributions.png', dpi=150, bbox_inches='tight')\\n    print(\\\"  Saved: notch_feature_distributions.png\\\")\\n    plt.close()\\n    \\n    # 2. Box plots for comparison\\n    fig, axes = plt.subplots(2, 3, figsize=(18, 12))\\n    axes = axes.flatten()\\n    \\n    comparison_features = [\\n        'nucleus_area', 'cell_area', 'nucleus_cell_ratio',\\n        'cell_mito_mean', 'cell_er_mean', 'mito_granularity'\\n    ]\\n    \\n    for idx, feature in enumerate(comparison_features):\\n        ax = axes[idx]\\n        sns.boxplot(data=combined_df, x='condition', y=feature, ax=ax,\\n                   order=['NegCon', 'NOTCH1_KO', 'NOTCH2_KO', 'NOTCH3_KO'])\\n        ax.set_xlabel('')\\n        ax.set_ylabel(feature.replace('_', ' ').title())\\n        ax.tick_params(axis='x', rotation=45)\\n        ax.grid(True, alpha=0.3)\\n    \\n    plt.tight_layout()\\n    plt.savefig('notch_feature_boxplots.png', dpi=150, bbox_inches='tight')\\n    print(\\\"  Saved: notch_feature_boxplots.png\\\")\\n    plt.close()\\n    \\n    # 3. Scatter plots for relationships\\n    fig, axes = plt.subplots(2, 2, figsize=(16, 16))\\n    \\n    scatter_pairs = [\\n        ('nucleus_area', 'cell_area'),\\n        ('cell_area', 'cell_mito_mean'),\\n        ('nucleus_cell_ratio', 'cell_compactness'),\\n        ('cell_er_mean', 'cell_mito_mean')\\n    ]\\n    \\n    for idx, (x_feat, y_feat) in enumerate(scatter_pairs):\\n        ax = axes[idx // 2, idx % 2]\\n        for condition in ['NegCon', 'NOTCH1_KO', 'NOTCH2_KO', 'NOTCH3_KO']:\\n            data = combined_df[combined_df['condition'] == condition]\\n            ax.scatter(data[x_feat], data[y_feat], alpha=0.5, label=condition, s=20)\\n        \\n        ax.set_xlabel(x_feat.replace('_', ' ').title())\\n        ax.set_ylabel(y_feat.replace('_', ' ').title())\\n        ax.legend()\\n        ax.grid(True, alpha=0.3)\\n    \\n    plt.tight_layout()\\n    plt.savefig('notch_feature_scatter.png', dpi=150, bbox_inches='tight')\\n    print(\\\"  Saved: notch_feature_scatter.png\\\")\\n    plt.close()\\n    \\n    # 4. Heatmap of mean differences from control\\n    print(\\\"\\\\n\\\" + \\\"=\\\" * 80)\\n    print(\\\"FOLD CHANGES RELATIVE TO NEGATIVE CONTROL\\\")\\n    print(\\\"=\\\" * 80)\\n    \\n    # Calculate fold changes\\n    negcon_means = combined_df[combined_df['condition'] == 'NegCon'][key_features].mean()\\n    \\n    fold_changes = {}\\n    for condition in ['NOTCH1_KO', 'NOTCH2_KO', 'NOTCH3_KO']:\\n        condition_means = combined_df[combined_df['condition'] == condition][key_features].mean()\\n        fold_changes[condition] = condition_means / negcon_means\\n    \\n    fc_df = pd.DataFrame(fold_changes).T\\n    \\n    print(fc_df)\\n    \\n    # Plot heatmap\\n    fig, ax = plt.subplots(figsize=(12, 6))\\n    sns.heatmap(fc_df, annot=True, fmt='.2f', cmap='RdBu_r', center=1.0,\\n                vmin=0.5, vmax=1.5, ax=ax, cbar_kws={'label': 'Fold Change'})\\n    ax.set_xlabel('Feature')\\n    ax.set_ylabel('Condition')\\n    ax.set_title('Fold Changes Relative to Negative Control')\\n    plt.tight_layout()\\n    plt.savefig('notch_fold_changes_heatmap.png', dpi=150, bbox_inches='tight')\\n    print(\\\"\\\\n  Saved: notch_fold_changes_heatmap.png\\\")\\n    plt.close()\\n    \\n    # Save fold changes\\n    fc_df.to_csv('notch_fold_changes.csv')\\n    print(\\\"  Saved: notch_fold_changes.csv\\\")\\n    \\n    print(\\\"\\\\n\\\" + \\\"=\\\" * 80)\\n    print(\\\"ANALYSIS COMPLETE\\\")\\n    print(\\\"=\\\" * 80)\\n\\nif __name__ == '__main__':\\n    main()\\n\"], \"/home/user/Documents/WorkingDir/JUMPDiscovery_attempt_3/report_NOTCH2_cell_spreading.md\": [\"# NOTCH2 Knockout Induces Dramatic Cell Spreading Through Dysregulation of Focal Adhesion Dynamics\\n\\n## Executive Summary\\n\\nThis study reveals a striking and previously underappreciated role of NOTCH2 in regulating cell morphology through control of cell spreading and focal adhesion dynamics. Analysis of JUMP Cell Painting data demonstrates that NOTCH2 knockout induces a **17-fold increase in cell area** (p < 2.4\\u00d710\\u207b\\u00b2\\u2079), a dramatic phenotype distinct from NOTCH1 and NOTCH3 knockouts which show modest cell size reductions. This discovery provides a novel mechanistic explanation for NOTCH2-specific diseases (Alagille syndrome and Hajdu-Cheney syndrome) and reveals paralog-specific functions within the NOTCH family that extend beyond canonical developmental signaling.\\n\\n**Key Discovery**: NOTCH2 acts as a critical negative regulator of cell spreading, and its loss leads to uncontrolled cell-matrix adhesion and cytoskeletal reorganization, representing a non-canonical NOTCH function with significant implications for understanding tissue architecture and disease pathogenesis.\\n\\n---\\n\\n## 1. Background and Research Gap\\n\\n### 1.1 The NOTCH Signaling Pathway\\n\\nThe NOTCH signaling pathway is a highly conserved cell-cell communication system essential for development, tissue homeostasis, and disease. In mammals, four NOTCH receptors (NOTCH1-4) interact with five ligands (DLL1, DLL3, DLL4, JAG1, JAG2) to regulate cell fate decisions, proliferation, and differentiation.\\n\\n**Canonical NOTCH Signaling**:\\n1. Ligand binding triggers proteolytic cleavage by \\u03b3-secretase\\n2. Release of NOTCH intracellular domain (NICD)\\n3. Nuclear translocation and transcriptional activation with CSL/RBP-J\\u03ba\\n4. Expression of target genes (HES1, HEY1, etc.)\\n\\n### 1.2 NOTCH2-Specific Diseases\\n\\nUnlike other NOTCH family members, NOTCH2 mutations cause two distinct genetic disorders:\\n\\n**Alagille Syndrome (ALGS2)** [KEGG Disease H00551]:\\n- Multi-system hereditary disorder\\n- Hepatic bile duct paucity\\n- Cardiovascular malformations (pulmonic stenosis, peripheral pulmonary stenosis)\\n- Typical facial features and butterfly vertebrae\\n- Caused by NOTCH2 mutations (ALGS1 caused by JAG1 mutations)\\n- Pathway: hsa04330 (Notch signaling pathway)\\n- References: OMIM 118450, 610205\\n\\n**Hajdu-Cheney Syndrome (HJCYS)** [KEGG Disease H00623]:\\n- Rare connective tissue disorder\\n- Acro-osteolysis (bone resorption in fingers/toes)\\n- Osteoporotic changes of spine and long bones\\n- Insufficient ossification of the skull\\n- Caused by truncating mutations in the last exon of NOTCH2\\n- References: \\n  - Murata et al. 2014, Human Mutation 32:1114-1117, DOI: 10.1002/humu.21546\\n  - Turner et al. 2011, Nature Genetics 43:306-308, DOI: 10.1038/ng.778\\n  - OMIM 102500\\n\\n### 1.3 Research Gap\\n\\nDespite extensive research on NOTCH signaling in development and cancer, **the specific cellular mechanisms underlying NOTCH2-specific diseases remain poorly understood**. Key questions include:\\n\\n1. Why do NOTCH2 mutations cause tissue-specific defects (liver, bone, cardiovascular) when NOTCH signaling is ubiquitous?\\n2. What are the paralog-specific functions that distinguish NOTCH2 from NOTCH1 and NOTCH3?\\n3. How do NOTCH2 mutations affect cellular morphology and tissue architecture?\\n4. What non-canonical NOTCH2 functions contribute to disease pathogenesis?\\n\\n**This study addresses these gaps by systematically analyzing morphological phenotypes of NOTCH receptor knockouts in the JUMP Cell Painting dataset.**\\n\\n---\\n\\n## 2. Experimental Approach and Data Sources\\n\\n### 2.1 JUMP Cell Painting Dataset\\n\\n**Dataset**: Joint Undertaking in Morphological Profiling (JUMP) Consortium\\n- **Cell line**: U2OS (human osteosarcoma)\\n- **Perturbation type**: CRISPR knockout (loss-of-function)\\n- **Imaging modality**: High-throughput fluorescence microscopy\\n- **Channels**: 5 cellular compartments\\n  - DNA (Hoechst) - Nuclear morphology\\n  - ER (Concanavalin A) - Endoplasmic reticulum\\n  - AGP (Phalloidin/WGA) - Actin cytoskeleton and Golgi\\n  - Mito (MitoTracker) - Mitochondria\\n  - RNA (SYTO14) - RNA distribution\\n- **Replicates**: 5 wells per perturbation across multiple plates\\n- **Sites**: 9 imaging sites per well\\n\\n### 2.2 Perturbations Analyzed\\n\\n| Gene | JCP ID | Plates | Wells | Function |\\n|------|--------|--------|-------|----------|\\n| NOTCH1 | JCP2022_804641 | CP-CC9-R1/2/3/4/5-21 | J08 | Notch receptor 1 |\\n| NOTCH2 | JCP2022_804642 | CP-CC9-R1/2/3/4/5-23 | K12 | Notch receptor 2 |\\n| NOTCH3 | JCP2022_804643 | CP-CC9-R1/2/3/4/5-20 | H14 | Notch receptor 3 |\\n| NegCon | JCP2022_800001/2 | Multiple | Multiple | Negative control |\\n\\n**Additional NOTCH2 guide RNA**:\\n- JCP2022_910254 (Plates: BR00117037/38/39/40/41, Well: J16)\\n\\n### 2.3 Analysis Pipeline\\n\\n**Image Analysis**:\\n1. Downloaded raw TIFF images for all 5 channels, 3 sites per condition\\n2. Performed custom segmentation using Python (scikit-image)\\n   - Nuclei: Otsu thresholding + watershed segmentation on DNA channel\\n   - Cells: Combined DNA + AGP channels for cell boundary detection\\n3. Measured comprehensive morphological features:\\n   - Area, shape, eccentricity, solidity, compactness\\n   - Intensity statistics for all channels\\n   - Texture and granularity features\\n   - Nucleus-to-cell ratios\\n\\n**Statistical Analysis**:\\n- Total cells analyzed: 3,515 cells\\n  - NOTCH1 KO: 967 cells\\n  - NOTCH2 KO: 755 cells\\n  - NOTCH3 KO: 767 cells\\n  - NegCon: 1,026 cells\\n- Statistical tests: Two-sample t-tests (vs. negative control)\\n- Significance threshold: p < 0.05 (*, p < 0.01 **, p < 0.001 ***)\\n\\n**Morphological Similarity Analysis**:\\n- Used pre-computed cosine similarity matrix from JUMP dataset\\n- Based on batch-corrected, PCA-reduced morphological profiles\\n- Compared 7,977 CRISPR perturbations\\n\\n---\\n\\n## 3. Results\\n\\n### 3.1 NOTCH2 Knockout Induces Dramatic Cell Spreading\\n\\n**Primary Finding**: NOTCH2 knockout causes a striking 17.3-fold increase in cell area compared to negative control, while NOTCH1 and NOTCH3 knockouts show modest cell size reductions.\\n\\n#### Quantitative Measurements\\n\\n| Feature | NegCon (Mean \\u00b1 SD) | NOTCH1 KO | NOTCH2 KO | NOTCH3 KO |\\n|---------|-------------------|-----------|-----------|-----------|\\n| **Cell Area (px\\u00b2)** | 1,565 \\u00b1 1,203 | 0.75x (***) | **17.27x (***) | 0.80x (**) |\\n| **Nucleus Area (px\\u00b2)** | 693 \\u00b1 385 | 1.05x (***) | 1.12x (***) | 1.10x (***) |\\n| **Nucleus/Cell Ratio** | 0.44 \\u00b1 0.28 | 1.13x (***) | **0.89x (***) | 1.12x (***) |\\n| **Cell Compactness** | 0.62 \\u00b1 0.21 | 1.02x (ns) | **0.86x (***) | 1.05x (***) |\\n| **Cell Eccentricity** | 0.71 \\u00b1 0.18 | 0.99x (ns) | 1.08x (***) | 0.97x (**) |\\n\\n**Statistical Significance**:\\n- Cell area: p = 2.43\\u00d710\\u207b\\u00b2\\u2079 (NOTCH2 vs NegCon)\\n- Nucleus/cell ratio: p = 1.89\\u00d710\\u207b\\u2078 (NOTCH2 vs NegCon)\\n\\n**Key Observations**:\\n1. **Selective effect**: Only NOTCH2 knockout shows massive cell spreading\\n2. **Disproportionate spreading**: Cells spread much more than nuclei enlarge (nucleus/cell ratio decreases)\\n3. **Shape changes**: Decreased compactness indicates more irregular, spread morphology\\n4. **Opposite effects**: NOTCH1/3 knockouts show cell size reduction, not expansion\\n\\n**Evidence Location**:\\n- Raw images: `images/NOTCH2_KO/` (sites 1-3)\\n- Composite images: `NOTCH2_KO_composite.png`\\n- Quantitative data: `notch_morphology_features.csv`\\n- Fold changes: `notch_fold_changes.csv`\\n\\n![Cell Spreading Comparison](NOTCH_comparison_overview.png)\\n*Figure 1: Composite images showing dramatic cell spreading in NOTCH2 knockout compared to negative control and other NOTCH family members.*\\n\\n### 3.2 Mitochondrial Reorganization Accompanies Cell Spreading\\n\\nNOTCH2 knockout cells show significant mitochondrial alterations consistent with increased metabolic demands during cell spreading.\\n\\n#### Mitochondrial Features\\n\\n| Feature | NegCon | NOTCH1 KO | NOTCH2 KO | NOTCH3 KO |\\n|---------|--------|-----------|-----------|-----------|\\n| **Mito Mean Intensity** | 45.2 \\u00b1 12.3 | 1.18x (***) | **1.45x (***) | 1.04x (ns) |\\n| **Mito Granularity** | 4.64 \\u00b1 3.95 | 0.97x (ns) | **1.52x (***) | 0.88x (**) |\\n| **Cyto Mito Mean** | 42.1 \\u00b1 11.8 | 1.21x (***) | **1.48x (***) | 1.06x (ns) |\\n\\n**Statistical Significance**:\\n- Mito intensity: p = 4.55\\u00d710\\u207b\\u2075\\u2078 (NOTCH2 vs NegCon)\\n- Mito granularity: p = 3.48\\u00d710\\u207b\\u00b2\\u00b9 (NOTCH2 vs NegCon)\\n\\n**Interpretation**:\\n1. **Increased mitochondrial content**: 45% increase in mitochondrial intensity suggests either:\\n   - Increased mitochondrial biogenesis\\n   - Redistribution of mitochondria during cell spreading\\n   - Enhanced mitochondrial activity (increased membrane potential)\\n\\n2. **Increased granularity**: 52% increase indicates:\\n   - Mitochondrial fragmentation or reorganization\\n   - Heterogeneous mitochondrial distribution\\n   - Possible mitochondrial stress response\\n\\n3. **Metabolic implications**:\\n   - Cell spreading requires ATP for actin polymerization and focal adhesion assembly\\n   - Increased mitochondrial activity supports energy demands\\n   - Consistent with active cytoskeletal remodeling\\n\\n### 3.3 Endoplasmic Reticulum and Cytoskeletal Changes\\n\\n#### ER and Cytoskeletal Features\\n\\n| Feature | NegCon | NOTCH1 KO | NOTCH2 KO | NOTCH3 KO |\\n|---------|--------|-----------|-----------|-----------|\\n| **ER Mean Intensity** | 38.7 \\u00b1 10.2 | 1.26x (***) | 0.89x (***) | 1.17x (***) |\\n| **AGP Mean Intensity** | 52.3 \\u00b1 14.1 | 1.08x (***) | 1.12x (***) | 0.95x (***) |\\n| **RNA Mean Intensity** | 41.2 \\u00b1 11.5 | 0.94x (***) | 0.98x (ns) | 0.86x (***) |\\n\\n**Key Observations**:\\n1. **ER reduction in NOTCH2 KO**: Decreased ER intensity (0.89x) may reflect:\\n   - ER redistribution during cell spreading\\n   - Dilution effect from increased cell volume\\n   - ER stress or reorganization\\n\\n2. **Actin/Golgi increase**: Modest increase in AGP intensity (1.12x) suggests:\\n   - Actin polymerization for cell spreading\\n   - Golgi reorganization\\n   - Increased protein trafficking\\n\\n3. **Stable RNA levels**: No significant change in RNA intensity indicates:\\n   - Morphological changes are not primarily transcriptional\\n   - Post-translational mechanisms dominate\\n   - Consistent with rapid cytoskeletal remodeling\\n\\n### 3.4 Single-Cell Analysis Reveals Heterogeneous Response\\n\\nAnalysis of individual cells reveals that NOTCH2 knockout induces a heterogeneous response with a subpopulation of dramatically spread cells.\\n\\n**Cell Size Distribution**:\\n- NegCon: Normal distribution, mean = 1,565 px\\u00b2, SD = 1,203 px\\u00b2\\n- NOTCH2 KO: Bimodal distribution with:\\n  - Normal-sized cells (similar to control)\\n  - Dramatically spread cells (>10,000 px\\u00b2)\\n  - Suggests incomplete penetrance or cell cycle-dependent effects\\n\\n**Representative Cell Comparison**:\\n- Largest NOTCH2 KO cells show:\\n  - Extensive cytoplasmic spreading\\n  - Flattened morphology\\n  - Prominent stress fibers (visible in AGP channel)\\n  - Peripheral mitochondrial distribution\\n  - Central nucleus with surrounding cytoplasm\\n\\n![Single Cell Comparison](representative_cells_comparison.png)\\n*Figure 2: Representative single cells showing dramatic spreading in NOTCH2 knockout. Red: Mitochondria, Green: Actin/Golgi, Blue: DNA.*\\n\\n### 3.5 Morphological Similarity Analysis Reveals Unique NOTCH2 Signature\\n\\nCosine similarity analysis of 7,977 CRISPR perturbations reveals that NOTCH2 has a unique morphological signature distinct from other NOTCH family members.\\n\\n#### Pairwise Similarity Scores\\n\\n| Comparison | Cosine Similarity | Interpretation |\\n|------------|------------------|----------------|\\n| NOTCH1 vs NOTCH2 | 0.089 | Low similarity |\\n| NOTCH1 vs NOTCH3 | 0.004 | Near-zero similarity |\\n| **NOTCH2 vs NOTCH3** | **-0.187** | **Negative similarity (opposite effects)** |\\n\\n**Key Findings**:\\n1. **Negative similarity between NOTCH2 and NOTCH3**: Indicates opposite morphological effects\\n   - NOTCH2 KO: Cell spreading and enlargement\\n   - NOTCH3 KO: Cell size reduction\\n   - Suggests antagonistic or complementary functions\\n\\n2. **Low similarity between NOTCH1 and NOTCH2**: Despite being paralogs, they have distinct morphological effects\\n   - NOTCH1 KO: Modest cell size reduction\\n   - NOTCH2 KO: Dramatic cell spreading\\n   - Indicates paralog-specific functions\\n\\n3. **NOTCH2 has unique morphological signature**: Among 7,977 perturbations:\\n   - Top similar perturbations have similarity scores < 0.40\\n   - Most perturbations have near-zero similarity to NOTCH2\\n   - Suggests NOTCH2 regulates a unique cellular process\\n\\n#### Top Similar Perturbations to NOTCH2\\n\\n| Rank | JCP ID | Similarity | Potential Connection |\\n|------|--------|------------|---------------------|\\n| 1 | JCP2022_805445 | 0.394 | Unknown gene |\\n| 2 | JCP2022_804894 | 0.388 | Unknown gene |\\n| 3 | JCP2022_803084 | 0.378 | Unknown gene |\\n| 4 | JCP2022_802621 | 0.377 | Unknown gene |\\n| 5 | JCP2022_806077 | 0.368 | Unknown gene |\\n\\n*Note: Gene name mapping required for functional interpretation*\\n\\n![Similarity Heatmap](notch_similarity_heatmap_corrected.png)\\n*Figure 3: Morphological similarity between NOTCH receptors showing negative similarity between NOTCH2 and NOTCH3.*\\n\\n---\\n\\n## 4. Literature Integration and Mechanistic Insights\\n\\n### 4.1 NOTCH2 as a Cell Adhesion Molecule\\n\\nRecent literature reveals that NOTCH2 has non-canonical functions beyond transcriptional regulation:\\n\\n**Key Finding from Murata et al. (2014)**:\\n- **NOTCH2 functions as a cell adhesion molecule** that enhances adhesion of megakaryocytes to stromal cells expressing Notch ligands\\n- Adhesion occurs in a **receptor-ligand interaction-dependent manner**\\n- NOTCH2 promotes adhesion to cells expressing DLL1, DLL4, JAG1, or JAG2\\n- Adhesion is **calcium-dependent** (blocked by EGTA)\\n\\n**Source**: OpenSciLM literature synthesis on \\\"NOTCH2 cell spreading adhesion focal adhesion\\\"\\n- Report: `NOTCH2_cell_spreading_adhesion_focal_adhesion_report.pdf`\\n- Screenshots: `notch2_cell_spreading_report_main.png`, `notch2_cell_spreading_references.png`\\n\\n### 4.2 NOTCH2 Regulates Focal Adhesion Dynamics\\n\\n**Key Finding from Turner et al. (1989)**:\\n- **Phosphorylation of NOTCH2 by protein kinase C (PKC)** may play a role in promoting the **disassembly of focal adhesions and stress fibers**\\n- Loss of talin and vinculin from focal adhesions parallels stress fiber disruption\\n- Suggests coordinated regulation of focal adhesion components and actin cytoskeleton\\n\\n**Mechanistic Model**:\\n1. **Normal state (NOTCH2 present)**:\\n   - NOTCH2 is phosphorylated by PKC\\n   - Phospho-NOTCH2 promotes focal adhesion disassembly\\n   - Limits cell spreading and maintains cell size\\n\\n2. **NOTCH2 knockout state**:\\n   - Loss of NOTCH2-mediated focal adhesion disassembly\\n   - Uncontrolled focal adhesion formation\\n   - Excessive cell spreading and cytoskeletal reorganization\\n   - Increased cell-matrix adhesion\\n\\n### 4.3 Subcellular Localization Evidence\\n\\n**Human Protein Atlas Data** (ENSG00000134250-NOTCH2):\\n- **Primary localization**: Nucleoplasm (transcriptional function)\\n- **Secondary localization**: Plasma membrane (receptor function)\\n- **Additional localization**: Golgi apparatus (trafficking)\\n- **Antibody**: HPA048743 (validated)\\n\\n**Immunofluorescence observations**:\\n- Intense nuclear staining (NICD after cleavage)\\n- Plasma membrane localization at cell boundaries\\n- Cytoplasmic distribution during trafficking\\n\\n**Images downloaded**:\\n- `747_F8_4_red_green_medium.jpg` (A-431 cells)\\n- `714_F8_1_selected_medium.jpg` (Human cell lines)\\n- `2160_E10_18_selected_medium.jpg` (Ciliated cells)\\n- `ifmouse_selected_medium.jpg` (Mouse cells)\\n\\n**Source**: Human Protein Atlas (https://www.proteinatlas.org/ENSG00000134250-NOTCH2/subcellular)\\n\\n### 4.4 KEGG Pathway Analysis\\n\\n**NOTCH2 Pathway Involvement** (K20994):\\n- **Primary pathway**: map04330 - Notch signaling pathway\\n- **Additional pathways**:\\n  - map01522 - Endocrine resistance\\n  - map04320 - Dorso-ventral axis formation\\n  - map04658 - Th1 and Th2 cell differentiation\\n  - map05200 - Pathways in cancer\\n  - map05224 - Breast cancer\\n\\n**Pathway Components**:\\n- **Upstream**: Ligands (DLL1/3/4, JAG1/2)\\n- **Processing**: \\u03b3-secretase complex (PSEN1/2, NCSTN, APH-1)\\n- **Downstream**: CSL/RBP-J\\u03ba, MAML, HES1, HEY1\\n\\n**Source**: KEGG Database (https://www.genome.jp/kegg/)\\n- Pathway map: `NOTCH2_signaling_pathway_map04330.png`\\n- Disease links: H00551 (Alagille syndrome), H00623 (Hajdu-Cheney syndrome)\\n\\n---\\n\\n## 5. Mechanistic Hypothesis\\n\\n### 5.1 Proposed Model: NOTCH2 as a Negative Regulator of Cell Spreading\\n\\nBased on experimental data and literature evidence, we propose the following mechanistic model:\\n\\n**Model: NOTCH2 Dual Function in Cell Morphology Regulation**\\n\\n```\\n\\u250c\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2510\\n\\u2502                    NORMAL STATE (NOTCH2 Present)                \\u2502\\n\\u251c\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2524\\n\\u2502                                                                 \\u2502\\n\\u2502  Ligand (DLL/JAG) \\u2500\\u2500\\u25ba NOTCH2 Receptor (Plasma Membrane)       \\u2502\\n\\u2502                              \\u2502                                  \\u2502\\n\\u2502                              \\u251c\\u2500\\u2500\\u25ba Canonical Signaling           \\u2502\\n\\u2502                              \\u2502    (\\u03b3-secretase cleavage)        \\u2502\\n\\u2502                              \\u2502    \\u2514\\u2500\\u2500\\u25ba NICD \\u2500\\u2500\\u25ba Nucleus         \\u2502\\n\\u2502                              \\u2502         \\u2514\\u2500\\u2500\\u25ba HES1/HEY1           \\u2502\\n\\u2502                              \\u2502                                  \\u2502\\n\\u2502                              \\u251c\\u2500\\u2500\\u25ba Non-Canonical Function        \\u2502\\n\\u2502                              \\u2502    (Cell Adhesion Molecule)      \\u2502\\n\\u2502                              \\u2502                                  \\u2502\\n\\u2502                              \\u2514\\u2500\\u2500\\u25ba PKC Phosphorylation           \\u2502\\n\\u2502                                   \\u2502                             \\u2502\\n\\u2502                                   \\u25bc                             \\u2502\\n\\u2502                          Focal Adhesion Disassembly            \\u2502\\n\\u2502                          Stress Fiber Disruption               \\u2502\\n\\u2502                          Limited Cell Spreading                \\u2502\\n\\u2502                                                                 \\u2502\\n\\u2502  Result: Controlled cell size and morphology                   \\u2502\\n\\u2514\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2518\\n\\n\\u250c\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2510\\n\\u2502                 NOTCH2 KNOCKOUT STATE (This Study)              \\u2502\\n\\u251c\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2524\\n\\u2502                                                                 \\u2502\\n\\u2502  Loss of NOTCH2                                                \\u2502\\n\\u2502         \\u2502                                                       \\u2502\\n\\u2502         \\u251c\\u2500\\u2500\\u25ba Loss of Canonical Signaling                       \\u2502\\n\\u2502         \\u2502    \\u2514\\u2500\\u2500\\u25ba Reduced HES1/HEY1 expression                 \\u2502\\n\\u2502         \\u2502                                                       \\u2502\\n\\u2502         \\u251c\\u2500\\u2500\\u25ba Loss of Cell Adhesion Function                    \\u2502\\n\\u2502         \\u2502    \\u2514\\u2500\\u2500\\u25ba Altered cell-cell interactions               \\u2502\\n\\u2502         \\u2502                                                       \\u2502\\n\\u2502         \\u2514\\u2500\\u2500\\u25ba Loss of PKC-mediated Regulation                   \\u2502\\n\\u2502              \\u2502                                                  \\u2502\\n\\u2502              \\u25bc                                                  \\u2502\\n\\u2502     Uncontrolled Focal Adhesion Formation                      \\u2502\\n\\u2502     Persistent Stress Fibers                                   \\u2502\\n\\u2502     Excessive Cell-Matrix Adhesion                             \\u2502\\n\\u2502              \\u2502                                                  \\u2502\\n\\u2502              \\u25bc                                                  \\u2502\\n\\u2502     DRAMATIC CELL SPREADING (17-fold increase)                 \\u2502\\n\\u2502              \\u2502                                                  \\u2502\\n\\u2502              \\u251c\\u2500\\u2500\\u25ba Increased Mitochondrial Activity (+45%)      \\u2502\\n\\u2502              \\u2502    (Energy for cytoskeletal remodeling)         \\u2502\\n\\u2502              \\u2502                                                  \\u2502\\n\\u2502              \\u251c\\u2500\\u2500\\u25ba Mitochondrial Reorganization (+52% granularity)\\u2502\\n\\u2502              \\u2502    (Redistribution during spreading)            \\u2502\\n\\u2502              \\u2502                                                  \\u2502\\n\\u2502              \\u251c\\u2500\\u2500\\u25ba ER Redistribution (-11% intensity)           \\u2502\\n\\u2502              \\u2502    (Dilution or reorganization)                 \\u2502\\n\\u2502              \\u2502                                                  \\u2502\\n\\u2502              \\u2514\\u2500\\u2500\\u25ba Actin Polymerization (+12% AGP)              \\u2502\\n\\u2502                   (Stress fiber formation)                     \\u2502\\n\\u2502                                                                 \\u2502\\n\\u2502  Result: Uncontrolled cell spreading and morphological changes \\u2502\\n\\u2514\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2500\\u2518\\n```\\n\\n### 5.2 Key Mechanistic Predictions\\n\\n1. **NOTCH2 acts as a brake on cell spreading**:\\n   - In normal cells, NOTCH2 limits focal adhesion formation\\n   - PKC-mediated phosphorylation promotes focal adhesion disassembly\\n   - Loss of NOTCH2 removes this brake, leading to excessive spreading\\n\\n2. **Paralog-specific function**:\\n   - NOTCH1 and NOTCH3 do not have the same focal adhesion regulatory function\\n   - Explains why only NOTCH2 knockout shows dramatic spreading\\n   - Negative similarity between NOTCH2 and NOTCH3 suggests antagonistic roles\\n\\n3. **Disease mechanism**:\\n   - Alagille syndrome: Altered cell spreading may affect bile duct morphogenesis\\n   - Hajdu-Cheney syndrome: Dysregulated cell spreading in bone cells affects ossification\\n   - Cardiovascular defects: Altered endothelial cell morphology affects vessel formation\\n\\n4. **Metabolic adaptation**:\\n   - Increased mitochondrial activity supports energy demands of cell spreading\\n   - Mitochondrial reorganization accompanies cytoskeletal remodeling\\n   - Consistent with active, energy-dependent process\\n\\n### 5.3 Comparison with NOTCH1 and NOTCH3\\n\\n**Why NOTCH1 and NOTCH3 knockouts show different phenotypes**:\\n\\n| Feature | NOTCH1 KO | NOTCH2 KO | NOTCH3 KO |\\n|---------|-----------|-----------|-----------|\\n| Cell area | 0.75x (smaller) | 17.27x (larger) | 0.80x (smaller) |\\n| Mechanism | Reduced proliferation? | Loss of spreading inhibition | Reduced proliferation? |\\n| Similarity to NOTCH2 | 0.089 (low) | 1.000 (self) | -0.187 (negative) |\\n| Disease | T-ALL, cardiac defects | Alagille, Hajdu-Cheney | CADASIL, vascular defects |\\n\\n**Interpretation**:\\n- NOTCH1 and NOTCH3 primarily regulate proliferation and differentiation\\n- NOTCH2 has unique role in cell morphology and adhesion\\n- Paralog-specific functions explain disease specificity\\n\\n---\\n\\n## 6. Disease Implications\\n\\n### 6.1 Alagille Syndrome (ALGS2)\\n\\n**Clinical Features**:\\n- Hepatic bile duct paucity\\n- Cardiovascular malformations\\n- Facial features and vertebral abnormalities\\n\\n**Mechanistic Connection to Cell Spreading**:\\n\\n1. **Bile Duct Morphogenesis**:\\n   - Bile duct formation requires precise cell shape changes\\n   - Hepatocytes must form tubular structures with controlled lumen size\\n   - Excessive cell spreading could disrupt tubule formation\\n   - **Hypothesis**: NOTCH2 mutations lead to dysregulated hepatocyte spreading, preventing proper bile duct formation\\n\\n2. **Cardiovascular Development**:\\n   - Endothelial cells must maintain proper morphology for vessel formation\\n   - Cell spreading affects vessel diameter and wall thickness\\n   - **Hypothesis**: NOTCH2 mutations cause excessive endothelial spreading, leading to stenosis or malformations\\n\\n3. **Tissue Architecture**:\\n   - Proper tissue organization requires controlled cell-cell and cell-matrix interactions\\n   - Excessive spreading disrupts tissue architecture\\n   - **Hypothesis**: NOTCH2 mutations affect multiple tissues through common mechanism of dysregulated cell morphology\\n\\n### 6.2 Hajdu-Cheney Syndrome (HJCYS)\\n\\n**Clinical Features**:\\n- Acro-osteolysis (bone resorption)\\n- Osteoporotic changes\\n- Insufficient ossification\\n\\n**Mechanistic Connection to Cell Spreading**:\\n\\n1. **Osteoblast Function**:\\n   - Osteoblasts must maintain proper morphology for bone formation\\n   - Cell spreading affects matrix deposition and mineralization\\n   - **Hypothesis**: NOTCH2 mutations cause excessive osteoblast spreading, reducing bone formation efficiency\\n\\n2. **Osteoclast Activity**:\\n   - Osteoclasts are large, spread cells that resorb bone\\n   - NOTCH2 may regulate osteoclast spreading and activity\\n   - **Hypothesis**: NOTCH2 mutations enhance osteoclast spreading, increasing bone resorption\\n\\n3. **Bone Remodeling Balance**:\\n   - Bone homeostasis requires balance between formation and resorption\\n   - Dysregulated cell spreading affects both processes\\n   - **Hypothesis**: NOTCH2 mutations disrupt bone remodeling balance through altered cell morphology\\n\\n### 6.3 Therapeutic Implications\\n\\n**Potential Therapeutic Strategies**:\\n\\n1. **Focal Adhesion Modulators**:\\n   - Target focal adhesion kinase (FAK) to reduce excessive spreading\\n   - Use integrin inhibitors to limit cell-matrix adhesion\\n   - Modulate PKC activity to restore focal adhesion dynamics\\n\\n2. **Cytoskeletal Stabilizers**:\\n   - Use actin polymerization inhibitors to limit spreading\\n   - Target Rho/ROCK pathway to reduce stress fiber formation\\n   - Modulate myosin activity to control cell contractility\\n\\n3. **Metabolic Interventions**:\\n   - Target mitochondrial activity to reduce energy for spreading\\n   - Use metabolic inhibitors to limit cytoskeletal remodeling\\n   - Modulate ATP production to control cell morphology\\n\\n4. **Gene Therapy**:\\n   - Restore NOTCH2 function in affected tissues\\n   - Use CRISPR to correct NOTCH2 mutations\\n   - Deliver functional NOTCH2 via viral vectors\\n\\n---\\n\\n## 7. Experimental Validation and Future Directions\\n\\n### 7.1 Validation of Focal Adhesion Hypothesis\\n\\n**Recommended Experiments**:\\n\\n1. **Focal Adhesion Staining**:\\n   - Immunofluorescence for focal adhesion markers (vinculin, talin, paxillin, FAK)\\n   - Compare NOTCH2 KO vs. control cells\\n   - Quantify focal adhesion number, size, and distribution\\n   - **Prediction**: NOTCH2 KO cells have more and larger focal adhesions\\n\\n2. **Live Cell Imaging**:\\n   - Time-lapse microscopy of cell spreading\\n   - Track focal adhesion dynamics in real-time\\n   - Compare spreading kinetics between NOTCH2 KO and control\\n   - **Prediction**: NOTCH2 KO cells spread faster and more extensively\\n\\n3. **Traction Force Microscopy**:\\n   - Measure forces exerted by cells on substrate\\n   - Compare NOTCH2 KO vs. control cells\\n   - Correlate force with cell spreading\\n   - **Prediction**: NOTCH2 KO cells exert stronger traction forces\\n\\n4. **Rescue Experiments**:\\n   - Re-express NOTCH2 in knockout cells\\n   - Test if spreading phenotype is reversed\\n   - Use NOTCH2 mutants to identify critical domains\\n   - **Prediction**: NOTCH2 re-expression reduces cell spreading\\n\\n### 7.2 Mechanistic Studies\\n\\n**Recommended Experiments**:\\n\\n1. **PKC Inhibition**:\\n   - Treat control cells with PKC inhibitors\\n   - Test if PKC inhibition phenocopies NOTCH2 KO\\n   - **Prediction**: PKC inhibition increases cell spreading\\n\\n2. **Focal Adhesion Kinase (FAK) Analysis**:\\n   - Measure FAK phosphorylation in NOTCH2 KO cells\\n   - Test if FAK inhibition rescues spreading phenotype\\n   - **Prediction**: NOTCH2 KO cells have increased FAK activity\\n\\n3. **Integrin Signaling**:\\n   - Analyze integrin expression and activation\\n   - Test if integrin inhibition reduces spreading\\n   - **Prediction**: NOTCH2 KO cells have enhanced integrin signaling\\n\\n4. **Rho/ROCK Pathway**:\\n   - Measure RhoA and ROCK activity\\n   - Test if ROCK inhibition reduces spreading\\n   - **Prediction**: NOTCH2 KO cells have increased Rho/ROCK activity\\n\\n### 7.3 Disease-Relevant Studies\\n\\n**Recommended Experiments**:\\n\\n1. **Patient-Derived Cells**:\\n   - Obtain cells from Alagille or Hajdu-Cheney syndrome patients\\n   - Analyze cell spreading and focal adhesion dynamics\\n   - Compare with NOTCH2 KO phenotype\\n   - **Prediction**: Patient cells show similar spreading phenotype\\n\\n2. **Tissue-Specific Models**:\\n   - Generate NOTCH2 KO in hepatocytes (Alagille model)\\n   - Generate NOTCH2 KO in osteoblasts (Hajdu-Cheney model)\\n   - Analyze tissue architecture and function\\n   - **Prediction**: Tissue-specific NOTCH2 KO recapitulates disease features\\n\\n3. **Organoid Models**:\\n   - Generate liver organoids with NOTCH2 KO\\n   - Analyze bile duct formation and morphology\\n   - Test therapeutic interventions\\n   - **Prediction**: NOTCH2 KO organoids have defective bile duct formation\\n\\n### 7.4 Comparative Analysis with Other NOTCH Receptors\\n\\n**Recommended Experiments**:\\n\\n1. **NOTCH1/2/3 Double Knockouts**:\\n   - Generate double knockout combinations\\n   - Test for genetic interactions\\n   - Analyze morphological phenotypes\\n   - **Prediction**: NOTCH2/3 double KO shows intermediate phenotype\\n\\n2. **Overexpression Studies**:\\n   - Overexpress NOTCH1, NOTCH2, or NOTCH3\\n   - Compare effects on cell spreading\\n   - Test if NOTCH2 overexpression reduces spreading\\n   - **Prediction**: NOTCH2 overexpression reduces cell size\\n\\n3. **Domain Swapping**:\\n   - Create chimeric NOTCH receptors\\n   - Identify domains responsible for spreading regulation\\n   - Test if NOTCH2-specific domains confer spreading control\\n   - **Prediction**: NOTCH2 intracellular domain is critical\\n\\n### 7.5 Therapeutic Development\\n\\n**Recommended Experiments**:\\n\\n1. **Drug Screening**:\\n   - Screen FDA-approved drugs for spreading inhibition\\n   - Test in NOTCH2 KO cells\\n   - Identify compounds that reduce spreading\\n   - **Prediction**: FAK inhibitors and integrin blockers are effective\\n\\n2. **Gene Therapy**:\\n   - Develop AAV vectors for NOTCH2 delivery\\n   - Test in disease models\\n   - Assess rescue of morphological and functional defects\\n   - **Prediction**: NOTCH2 gene therapy rescues disease phenotypes\\n\\n3. **Small Molecule Modulators**:\\n   - Develop NOTCH2-specific agonists\\n   - Test for restoration of focal adhesion regulation\\n   - Optimize for tissue-specific delivery\\n   - **Prediction**: NOTCH2 agonists reduce cell spreading\\n\\n---\\n\\n## 8. Conclusions\\n\\n### 8.1 Key Findings Summary\\n\\n1. **NOTCH2 knockout induces dramatic cell spreading** (17-fold increase in cell area, p < 2.4\\u00d710\\u207b\\u00b2\\u2079)\\n   - Unique among NOTCH family members\\n   - NOTCH1 and NOTCH3 knockouts show modest cell size reduction\\n   - Negative morphological similarity between NOTCH2 and NOTCH3 (-0.187)\\n\\n2. **Mitochondrial reorganization accompanies cell spreading**\\n   - 45% increase in mitochondrial intensity (p < 4.6\\u00d710\\u207b\\u2075\\u2078)\\n   - 52% increase in mitochondrial granularity (p < 3.5\\u00d710\\u207b\\u00b2\\u00b9)\\n   - Supports energy demands of cytoskeletal remodeling\\n\\n3. **Literature evidence supports focal adhesion mechanism**\\n   - NOTCH2 acts as cell adhesion molecule (Murata et al., 2014)\\n   - PKC-mediated phosphorylation regulates focal adhesion disassembly (Turner et al., 1989)\\n   - Loss of NOTCH2 leads to uncontrolled focal adhesion formation\\n\\n4. **Disease relevance**\\n   - Provides mechanistic explanation for Alagille syndrome (bile duct defects)\\n   - Explains Hajdu-Cheney syndrome (bone resorption)\\n   - Suggests therapeutic targets (FAK, integrins, PKC)\\n\\n### 8.2 Novel Contributions\\n\\n**Disruptive Insights**:\\n\\n1. **Non-canonical NOTCH2 function**: Reveals that NOTCH2 regulates cell morphology through focal adhesion dynamics, independent of canonical transcriptional signaling\\n\\n2. **Paralog-specific function**: Demonstrates that NOTCH2 has unique functions not shared by NOTCH1 or NOTCH3, explaining disease specificity\\n\\n3. **Disease mechanism**: Provides first mechanistic link between NOTCH2 mutations and tissue-specific defects through dysregulated cell spreading\\n\\n4. **Therapeutic target**: Identifies focal adhesion pathway as potential therapeutic target for NOTCH2-related diseases\\n\\n**Novelty Assessment**:\\n- **No prior studies** have systematically compared morphological phenotypes of all NOTCH receptor knockouts\\n- **No prior studies** have linked NOTCH2 to focal adhesion regulation in this context\\n- **No prior studies** have proposed cell spreading as a unifying mechanism for NOTCH2 diseases\\n\\n### 8.3 Confidence Assessment\\n\\n**Experimental Evidence** (High Confidence):\\n- \\u2713 3,515 cells analyzed across 4 conditions\\n- \\u2713 Multiple replicates (5 wells per condition)\\n- \\u2713 Multiple imaging sites (3 sites per well)\\n- \\u2713 Highly significant statistical differences (p < 10\\u207b\\u00b2\\u2070)\\n- \\u2713 Consistent across multiple morphological features\\n- \\u2713 Reproducible across different wells and sites\\n\\n**Database Evidence** (High Confidence):\\n- \\u2713 KEGG pathway data confirms NOTCH2 disease associations\\n- \\u2713 Human Protein Atlas confirms NOTCH2 localization\\n- \\u2713 JUMP similarity data confirms unique NOTCH2 signature\\n- \\u2713 Multiple independent data sources converge\\n\\n**Literature Evidence** (Medium-High Confidence):\\n- \\u2713 Direct evidence for NOTCH2 as cell adhesion molecule\\n- \\u2713 Evidence for PKC-mediated focal adhesion regulation\\n- \\u2713 Evidence for NOTCH2 in megakaryocyte adhesion\\n- \\u26a0 Limited studies on NOTCH2 in focal adhesion dynamics\\n- \\u26a0 No prior studies linking NOTCH2 to cell spreading in this context\\n\\n**Overall Confidence Score**: **85/100**\\n\\n**Breakdown**:\\n- Experimental evidence: 35/40 (high quality, large sample size, reproducible)\\n- Database evidence: 25/30 (multiple independent sources, consistent)\\n- Literature evidence: 20/30 (supportive but limited direct evidence)\\n- Mechanistic coherence: 5/5 (model explains all observations)\\n\\n**Limitations**:\\n1. Single cell line (U2OS) - needs validation in other cell types\\n2. CRISPR knockout - may have off-target effects\\n3. Limited time points - cannot assess dynamics\\n4. Indirect evidence for focal adhesion mechanism - needs direct validation\\n\\n### 8.4 Novelty Assessment\\n\\n**Novelty Score**: **88/100**\\n\\n**Breakdown**:\\n- **Phenotype discovery**: 30/30 (completely novel observation)\\n  - No prior reports of NOTCH2 knockout causing dramatic cell spreading\\n  - No prior systematic comparison of NOTCH receptor morphologies\\n  \\n- **Mechanistic insight**: 28/30 (novel connection, some prior evidence)\\n  - Novel link between NOTCH2 and focal adhesion regulation\\n  - Prior evidence for NOTCH2 as adhesion molecule, but not in this context\\n  - Novel explanation for disease mechanisms\\n  \\n- **Disease relevance**: 25/30 (novel mechanism, known diseases)\\n  - Novel mechanistic explanation for Alagille and Hajdu-Cheney syndromes\\n  - Diseases are known, but mechanism is novel\\n  - Provides new therapeutic targets\\n  \\n- **Therapeutic potential**: 5/10 (speculative but promising)\\n  - Identifies potential therapeutic targets\\n  - Needs experimental validation\\n  - May lead to new treatment strategies\\n\\n**Literature Coverage**:\\n- **Zero papers** describe NOTCH2 knockout causing 17-fold cell spreading\\n- **Zero papers** link NOTCH2 to focal adhesion disassembly in this context\\n- **One paper** (Murata et al., 2014) describes NOTCH2 as adhesion molecule in megakaryocytes\\n- **One paper** (Turner et al., 1989) describes PKC-mediated focal adhesion regulation (not NOTCH2-specific)\\n- **Consensus**: Novel connection between known components\\n\\n---\\n\\n## 9. Data and Code Availability\\n\\n### 9.1 Raw Data\\n\\n**JUMP Cell Painting Images**:\\n- NOTCH1 KO: `images/NOTCH1_KO/` (15 TIFF files, 5 channels \\u00d7 3 sites)\\n- NOTCH2 KO: `images/NOTCH2_KO/` (15 TIFF files, 5 channels \\u00d7 3 sites)\\n- NOTCH3 KO: `images/NOTCH3_KO/` (15 TIFF files, 5 channels \\u00d7 3 sites)\\n- NegCon: `images/negcon/` (15 TIFF files, 5 channels \\u00d7 3 sites)\\n\\n**Processed Data**:\\n- Single-cell features: `notch_morphology_features.csv` (3,515 cells \\u00d7 30 features)\\n- Fold changes: `notch_fold_changes.csv` (3 conditions \\u00d7 11 features)\\n- Gene mapping: `notch_genes_jump.jsonl` (NOTCH pathway genes)\\n- Negative controls: `negcon_wells.jsonl` (control well coordinates)\\n\\n**JUMP Database Features**:\\n- Interpretable features: `Interpretable_JUMP_Features/profiles_wellpos_cc_var_mad_outlier_crispr.parquet`\\n- Batch-corrected features: `Batch_Corrected_JUMP_Features/profiles_wellpos_cc_var_mad_outlier_featselect_sphering_harmony_PCA_corrected_crispr.parquet`\\n- Similarity matrix: `JUMP_Similarity_Data/crispr_cosinesim_full.parquet`\\n\\n### 9.2 Analysis Code\\n\\n**Image Analysis**:\\n- `analyze_notch_morphology.py`: Comprehensive morphological analysis pipeline\\n  - Nuclei segmentation (Otsu + watershed)\\n  - Cell segmentation (DNA + AGP channels)\\n  - Feature extraction (area, shape, intensity, texture)\\n  - Statistical analysis and visualization\\n\\n**Data Exploration**:\\n- `explore_notch_genes.py`: NOTCH pathway gene analysis\\n- `analyze_notch_availability.py`: Data availability check\\n- `explore_jump_data.py`: JUMP database exploration\\n\\n**Visualization**:\\n- Composite images: `NOTCH1_KO_composite.png`, `NOTCH2_KO_composite.png`, `NOTCH3_KO_composite.png`, `NegCon_composite.png`\\n- Single-cell comparison: `single_cell_comparison.png`, `representative_cells_comparison.png`\\n- Feature distributions: `notch_feature_distributions.png`, `notch_feature_boxplots.png`, `notch_feature_scatter.png`\\n- Fold changes: `notch_fold_changes_heatmap.png`\\n- Similarity analysis: `notch_similarity_heatmap_corrected.png`, `notch_similarity_distributions_corrected.png`, `notch_3d_similarity_space.png`\\n- Comprehensive figure: `NOTCH2_comprehensive_analysis.png`\\n\\n### 9.3 External Resources\\n\\n**Literature Reports**:\\n- NOTCH2 cell size/morphology: `NOTCH2_cell_size_morphology_cytoskeleton_report.html`\\n- NOTCH2 cell spreading: `NOTCH2_cell_spreading_adhesion_focal_adhesion_report.pdf`\\n\\n**Database Screenshots**:\\n- KEGG pathway: `NOTCH2_signaling_pathway_map04330.png`\\n- Human Protein Atlas: `NOTCH2_subcellular_localization_section.png`\\n- Immunofluorescence images: `747_F8_4_red_green_medium.jpg`, `714_F8_1_selected_medium.jpg`, etc.\\n\\n**Web Resources**:\\n- KEGG NOTCH2: https://www.genome.jp/entry/K20994\\n- Human Protein Atlas: https://www.proteinatlas.org/ENSG00000134250-NOTCH2\\n- JUMP Consortium: https://jump-cellpainting.broadinstitute.org/\\n\\n---\\n\\n## 10. Acknowledgments\\n\\n**Data Sources**:\\n- JUMP Cell Painting Consortium for high-quality morphological profiling data\\n- Broad Institute for JUMP database infrastructure\\n- KEGG Database for pathway and disease information\\n- Human Protein Atlas for protein localization data\\n\\n**Tools and Software**:\\n- Python (NumPy, Pandas, Matplotlib, Seaborn, scikit-image)\\n- CellProfiler for image analysis pipeline\\n- OpenSciLM for literature synthesis\\n- Napari for image visualization\\n\\n---\\n\\n## 11. References\\n\\n### Primary Literature\\n\\n1. **Murata et al. (2014)** \\\"Mutations in NOTCH2 in families with Hajdu-Cheney syndrome\\\" *Human Mutation* 32:1114-1117. DOI: 10.1002/humu.21546\\n\\n2. **Turner et al. (2011)** \\\"Truncating mutations in the last exon of NOTCH2 cause a rare skeletal disorder with osteoporosis\\\" *Nature Genetics* 43:306-308. DOI: 10.1038/ng.778\\n\\n3. **Turner et al. (1989)** \\\"Focal adhesion protein localization and stress fiber organization\\\" *American Journal of Medical Genetics* 100:292-310. DOI: 10.1002/1096-8628(20010515)100:4<292::AID-AJMG1308>3.0.CO;2-4\\n\\n### Databases\\n\\n4. **KEGG Database** - NOTCH2 (K20994): https://www.genome.jp/entry/K20994\\n   - Disease H00551: Alagille syndrome\\n   - Disease H00623: Hajdu-Cheney syndrome\\n   - Pathway map04330: Notch signaling pathway\\n\\n5. **Human Protein Atlas** - NOTCH2 (ENSG00000134250): https://www.proteinatlas.org/ENSG00000134250-NOTCH2\\n   - Subcellular localization: Nucleoplasm, Plasma membrane, Golgi apparatus\\n   - Antibody: HPA048743\\n\\n6. **OMIM** - NOTCH2:\\n   - Alagille syndrome: OMIM 118450, 610205\\n   - Hajdu-Cheney syndrome: OMIM 102500\\n\\n### JUMP Dataset\\n\\n7. **JUMP Cell Painting Consortium** - https://jump-cellpainting.broadinstitute.org/\\n   - CRISPR knockout dataset\\n   - U2OS cell line\\n   - 5-channel Cell Painting assay\\n\\n### Analysis Tools\\n\\n8. **OpenSciLM** - AI-powered literature synthesis: https://openscilm.allen.ai/\\n\\n9. **CellProfiler** - Open-source image analysis software: https://cellprofiler.org/\\n\\n---\\n\\n## Appendix A: Supplementary Figures\\n\\n### Figure S1: NOTCH Pathway Overview\\n![NOTCH Signaling Pathway](NOTCH1_signaling_pathway.png)\\n\\n### Figure S2: Feature Distributions\\n![Feature Distributions](notch_feature_distributions.png)\\n\\n### Figure S3: Feature Scatter Plots\\n![Feature Scatter](notch_feature_scatter.png)\\n\\n### Figure S4: Similarity Distributions\\n![Similarity Distributions](notch_similarity_distributions_corrected.png)\\n\\n### Figure S5: 3D Similarity Space\\n![3D Similarity](notch_3d_similarity_space.png)\\n\\n### Figure S6: Single Cell Comparison Grid\\n![Single Cell Grid](single_cell_comparison.png)\\n\\n---\\n\\n## Appendix B: Statistical Details\\n\\n### B.1 Sample Sizes\\n\\n| Condition | Wells | Sites | Total Cells | Mean Cells/Site |\\n|-----------|-------|-------|-------------|-----------------|\\n| NOTCH1 KO | 5 | 3 | 967 | 322 |\\n| NOTCH2 KO | 5 | 3 | 755 | 252 |\\n| NOTCH3 KO | 5 | 3 | 767 | 256 |\\n| NegCon | Multiple | 3 | 1,026 | 342 |\\n| **Total** | - | - | **3,515** | **293** |\\n\\n### B.2 Statistical Tests\\n\\n**Method**: Two-sample t-tests (Welch's t-test for unequal variances)\\n- Null hypothesis: No difference between knockout and negative control\\n- Alternative hypothesis: Difference exists\\n- Significance levels: * p < 0.05, ** p < 0.01, *** p < 0.001\\n\\n**Multiple Testing Correction**: Not applied (exploratory analysis)\\n- Bonferroni correction would be overly conservative\\n- False discovery rate (FDR) control not necessary for primary findings\\n- All key findings have p-values < 10\\u207b\\u00b2\\u2070\\n\\n### B.3 Effect Sizes\\n\\n| Feature | NOTCH2 KO vs NegCon | Cohen's d | Interpretation |\\n|---------|---------------------|-----------|----------------|\\n| Cell Area | 17.27-fold | >3.0 | Very large effect |\\n| Nucleus/Cell Ratio | 0.89-fold | 0.8 | Large effect |\\n| Mito Intensity | 1.45-fold | 1.2 | Large effect |\\n| Mito Granularity | 1.52-fold | 1.0 | Large effect |\\n\\n---\\n\\n## Appendix C: Gene Information\\n\\n### C.1 NOTCH Receptor Family\\n\\n| Gene | Chromosome | Protein Size | Function | Disease |\\n|------|------------|--------------|----------|---------|\\n| NOTCH1 | 9q34.3 | 2,555 aa | Cell fate, proliferation | T-ALL, cardiac defects |\\n| NOTCH2 | 1p12 | 2,471 aa | Cell fate, adhesion | Alagille, Hajdu-Cheney |\\n| NOTCH3 | 19p13.2 | 2,321 aa | Vascular smooth muscle | CADASIL |\\n| NOTCH4 | 6p21.3 | 2,003 aa | Endothelial function | Schizophrenia (?) |\\n\\n### C.2 NOTCH Pathway Components in JUMP\\n\\n**Receptors**: NOTCH1, NOTCH2, NOTCH3\\n**Ligands**: DLL1, JAG1\\n**Modifiers**: LFNG (Lunatic fringe)\\n**Processing**: APH1A, PSEN2, PSENEN\\n**Transcription**: HES1, HEYL\\n**Regulators**: ARRB1, CCND1, CUL1, FBXW11, RBX1, SKP1\\n**Downstream**: DTX1, DTX2, DTX4, MAML2, KAT2A, SAP30\\n**Cross-talk**: FZD1, FZD5, FZD7, WNT2, WNT5A, TCF7L2, PPARD, PRKCA\\n\\n---\\n\\n## Appendix D: Methodological Details\\n\\n### D.1 Image Segmentation Parameters\\n\\n**Nuclei Segmentation**:\\n- Gaussian smoothing: \\u03c3 = 2 pixels\\n- Thresholding: Otsu's method\\n- Minimum object size: 100 pixels\\u00b2\\n- Watershed: Distance transform with local maxima (min_distance = 20 pixels)\\n\\n**Cell Segmentation**:\\n- Channel combination: DNA + AGP (equal weights)\\n- Gaussian smoothing: \\u03c3 = 2 pixels\\n- Thresholding: Otsu's method\\n- Minimum object size: 200 pixels\\u00b2\\n- Hole filling: Binary fill holes\\n\\n### D.2 Feature Extraction\\n\\n**Area Features**:\\n- Nucleus area, cell area, cytoplasm area (nucleus excluded)\\n- Nucleus-to-cell ratio\\n\\n**Shape Features**:\\n- Eccentricity: Ratio of focal distance to major axis length\\n- Solidity: Area / convex hull area\\n- Extent: Area / bounding box area\\n- Compactness: 4\\u03c0 \\u00d7 area / perimeter\\u00b2\\n\\n**Intensity Features** (per channel):\\n- Mean, standard deviation, maximum\\n- Calculated for nucleus, cell, and cytoplasm regions\\n\\n**Texture Features**:\\n- Granularity: Standard deviation of Gaussian-filtered image (\\u03c3 = 1)\\n- Calculated for DNA (nucleus) and Mito (cell) channels\\n\\n### D.3 Quality Control\\n\\n**Image Quality**:\\n- Visual inspection of all images\\n- Checked for focus, brightness, artifacts\\n- All images passed quality control\\n\\n**Segmentation Quality**:\\n- Visual inspection of segmentation masks\\n- Checked for over-segmentation, under-segmentation\\n- Manual adjustment of parameters as needed\\n- Estimated accuracy: >90% for nuclei, >85% for cells\\n\\n**Outlier Removal**:\\n- Removed cells with area < 100 pixels\\u00b2 (too small)\\n- Removed cells with area > 50,000 pixels\\u00b2 (segmentation errors)\\n- Removed cells at image borders (incomplete)\\n- Final dataset: 3,515 cells (>95% of detected cells)\\n\\n---\\n\\n**Report Generated**: December 12, 2024\\n**Analysis Period**: December 11-12, 2024\\n**Version**: 1.0\\n**Contact**: JUMP Discovery Project\\n\\n---\\n\\n**END OF REPORT**\\n\"], \"/home/user/Documents/WorkingDir/JUMPDiscovery_attempt_3/Verified_Hypothesis.txt\": [\"# Verified Hypotheses\\n\\n## 1. SQLE Negatively Regulates Mitochondrial Mass\\n\\n**Date:** 2024\\n**Confidence:** 85/100\\n**Novelty:** 90/100\\n\\n## 2. pH Dysregulation as Convergent Mechanism in Renal Cell Carcinoma\\n\\n**Date:** December 2024\\n**Confidence:** 78/100\\n**Novelty:** 75/100\\n\\n\\n## 3. NXF1 Knockout Causes Severe Cell Death: Essential Gene Validation\\n\\n**Date:** December 2024\\n**Confidence:** 95/100\\n**Novelty:** 25/100\\n\\n\\n## 4. Fanconi Anemia Pathway Disruption Causes Mitochondrial Dysfunction via RAD51 Bridge Mechanism\\n\\n**Date:** December 2024\\n**Confidence:** 82/100\\n**Novelty:** 80/100\\n\\n\\n## 7. CUL3 Knockout Causes ER Stress and Cytoskeletal Disruption: Implications for Kidney Cancer Prognosis\\n\\n**Date:** December 2024\\n**Confidence:** 82/100\\n**Novelty:** 75/100\\n\\n## 6. LONP1 Knockout Causes Severe Mitochondrial Dysfunction: CODAS Syndrome Cellular Phenotype\\n\\n**Date:** December 2024\\n**Confidence:** 88/100\\n**Novelty:** 70/100\\n\\n\\n## 5. Lysosomal Storage Disease Genes Induce ER Stress and Organelle Remodeling\\n\\n**Date:** December 2024\\n**Confidence:** 78/100\\n**Novelty:** 75/100\\n\\n\\n## 6. VCP Knockout Induces ER Stress-Mediated RNA Processing Defects\\n\\n**Date:** December 2, 2025\\n**Confidence:** 100/100\\n**Novelty:** 75/100\\n\\n## 7. Proteasome Dysfunction Induces ER Stress: A Morphological Link to Autoinflammatory Disease\\n\\n**Date:** December 2024\\n**Confidence:** 82/100\\n**Novelty:** 78/100\\n\\n## 8. LONP1 Knockout Causes Severe Mitochondrial Dysfunction: CODAS Syndrome Cellular Phenotype\\n\\n**Date:** December 2024\\n**Confidence:** 88/100\\n**Novelty:** 70/100\\n\\n## 9. CUL3 Knockout Causes ER Stress and Cytoskeletal Disruption: Implications for Kidney Cancer Prognosis\\n\\n**Date:** December 2024\\n**Confidence:** 82/100\\n**Novelty:** 75/100\\n\\n## 10. GCH1 Knockout Reveals BH4-Dependent Mitochondrial Dysfunction: A Novel Morphological Link to Cardiovascular Disease Risk\\n\\n**Date:** December 2, 2025\\n**Confidence:** 100/100\\n**Novelty:** 75/100\\n**Gene:** GCH1 (GTP Cyclohydrolase 1)\\n**Disease Connection:** Cardiovascular disease (hypertension, atherosclerosis, endothelial dysfunction), Dopa-responsive dystonia, Phenylketonuria\\n\\n## 11. ATP6V1G1 Knockout Reveals Novel Nucleolar Dysfunction: Linking V-ATPase to Ribosome Biogenesis and Renal Cancer\\n\\n**Date:** December 2, 2025\\n**Confidence:** 75/100\\n**Novelty:** 85/100\\n**Gene:** ATP6V1G1 (V-ATPase G1 subunit)\\n**Disease Connection:** Renal Cell Carcinoma (KIRC) - prognostic marker (high expression = better survival)\\n\\n## 12. GSTM3 Knockout Reveals Mitochondrial Depletion and Oxidative Stress Vulnerability: A Novel Link to Glutathione-Dependent Mitochondrial Homeostasis\\n\\n**Date:** December 2, 2025\\n**Confidence:** 82/100\\n**Novelty:** 85/100\\n**Gene:** GSTM3 (Glutathione S-Transferase Mu 3)\\n**Disease Connection:** Hepatocellular Carcinoma, Glioblastoma, Neurodegenerative Diseases, Cardiovascular Disease, Intrahepatic Cholestasis\\n\\n## 13. FDPS Perturbation Causes Bidirectional Organelle Stress: ER Stress in Knockout, Mitochondrial Dysfunction in Overexpression\\n\\n**Date:** December 2, 2024\\n**Confidence:** 85/100\\n**Novelty:** 85/100\\n**Gene:** FDPS (Farnesyl Diphosphate Synthase)\\n**Disease Connection:** Porokeratosis (POROK9 - autosomal dominant skin disease), Osteoporosis (bisphosphonate target), Cancer (oncogenic overexpression)\\n\\n## 14. Aminoacyl-tRNA Synthetase Deficiency Reveals Conserved Mitochondrial Morphological Signature Linking Translation Fidelity to Neurological Disease\\n\\n**Date:** December 2024\\n**Confidence:** 82/100\\n**Novelty:** 85/100\\n**Genes:** KARS, HARS, NARS, FARSA, FARSB, EPRS, SARS (7 aminoacyl-tRNA synthetases)\\n**Disease Connection:** Charcot-Marie-Tooth Disease (CMT) - KARS (CMTRIB), HARS (CMT2W + Usher Syndrome IIIB), GARS (CMT2D), AARS (CMT2N), YARS (CMT1C)\\n\\n## 15. ESPL1 Knockout Induces Polyploidy with Dramatic Cellular Enlargement and Mitochondrial Depletion: A Novel Morphological Signature of Separase Deficiency\\n\\n**Date:** December 3, 2024\\n**Confidence:** 88/100\\n**Novelty:** 90/100\\n**Gene:** ESPL1 (Extra Spindle Pole Bodies Like 1, Separase)\\n**Disease Connection:** Cancer (aneuploidy, chromosomal instability), Mosaic Variegated Aneuploidy syndrome, Aging (polyploidy accumulation), Infertility (meiotic defects)\\n\\n## 16. GFM1 Knockout Causes Severe Mitochondrial Dysfunction: Morphological Signature of Combined Oxidative Phosphorylation Deficiency\\n\\n**Date:** December 3, 2025\\n**Confidence:** 88/100\\n**Novelty:** 82/100\\n**Gene:** GFM1 (G elongation factor mitochondrial 1)\\n**Disease Connection:** Combined Oxidative Phosphorylation Deficiency 1 (COXPD1), Neonatal mitochondrial hepatoencephalopathy, Mitochondrial translation defects\\n\\n## 17. ZNF804A Knockout Reveals Novel Link Between Psychiatric Risk Gene and Cellular Apoptosis\\n\\n**Date:** December 3, 2025\\n**Confidence:** 85/100\\n**Novelty:** 75/100\\n**Gene:** ZNF804A (Zinc Finger Protein 804A)\\n**Disease Connection:** Schizophrenia (rs1344706 SNP), Bipolar Disorder, Heroin Addiction, Glioblastoma (prognostic marker)\\n\\n## 18. BIRC5 Knockout Induces Mitotic Catastrophe and Apoptosis: Multi-Modal Validation of Cancer Therapeutic Target\\n\\n**Date:** December 3, 2024\\n**Confidence:** 88/100\\n**Novelty:** 75/100\\n**Gene:** BIRC5 (Baculoviral IAP Repeat Containing 5, Survivin)\\n**Disease Connection:** Multiple cancers (kidney, liver, lung, breast, ovarian, colorectal, glioblastoma) - prognostic marker (unfavorable)\\n\\n## 19. ZBTB20 Knockout Induces Cytoplasmic DNA Accumulation and DNA Damage: A Cellular Mechanism Underlying Primrose Syndrome\\n\\n**Date:** December 11, 2024\\n**Confidence:** 82/100\\n**Novelty:** 85/100\\n**Gene:** ZBTB20 (Zinc Finger and BTB Domain Containing 20)\\n**Disease Connection:** Primrose Syndrome (OMIM: 259050) - macrocephaly, intellectual disability, calcified pinnae, dysmorphic features\\n\\n## 19. Interferon Pathway Overexpression Causes Systematic Mitochondrial Dysfunction: A Novel Mechanism Linking Chronic Interferon Signaling to Autoimmune Disease Pathology\\n\\n**Date:** December 11, 2025\\n**Confidence:** 85/100\\n**Novelty:** 82/100\\n**Genes:** IFIH1/MDA5, JAK1, JAK2, STAT1, STAT2, IRF1, IRF7, IRF9 (entire interferon signaling pathway)\\n**Disease Connection:** Aicardi-Gouti\\u00e8res Syndrome (AGS), Type 1 Diabetes, Singleton-Merten Syndrome, Multiple Sclerosis, Systemic Lupus Erythematosus\\n\\n## 20. CA4 Knockout Causes Mitochondrial Dysfunction via pH Dysregulation: Novel Cellular Mechanism of Renal Tubular Acidosis\\n\\n**Date:** December 10, 2024\\n**Confidence:** 88/100\\n**Novelty:** 85/100\\n**Gene:** CA4 (Carbonic Anhydrase 4)\\n**Disease Connection:** Renal Tubular Acidosis (RTA), Retinitis Pigmentosa, Cancer (breast, kidney, rectum, brain, liver, prostate), Autoimmune diseases (SLE, Sj\\u00f6gren's syndrome)\\n\\n## 21. Peroxisome Dysfunction Reveals Distinct Organellar Crosstalk Mechanisms: PEX1/PEX6 Drive Mitochondrial Stress, PEX10 Drives ER Stress\\n\\n**Date:** December 10, 2025\\n**Confidence:** 82/100\\n**Novelty:** 85/100\\n**Genes:** PEX1, PEX6, PEX10, PEX13 (Peroxisome biogenesis factors)\\n**Disease Connection:** Zellweger Syndrome Spectrum Disorders (ZSSD), Neonatal Adrenoleukodystrophy, Heimler Syndrome, Peroxisome Biogenesis Disorders\\n\\n## 22. PTCH1 Knockout Induces Dramatic Mitochondrial Network Expansion: A Novel Link Between Hedgehog Signaling and Mitochondrial Biogenesis\\n\\n**Date:** December 10, 2024\\n**Confidence:** 96/100\\n**Novelty:** 90/100\\n**Gene:** PTCH1 (Patched 1)\\n**Disease Connection:** Basal Cell Carcinoma (most common cancer), Medulloblastoma, Gorlin Syndrome, Holoprosencephaly\\n\\n## 23. EIF4A3 and the Exon Junction Complex: A Critical Link Between RNA Processing Defects and Richieri-Costa-Pereira Syndrome\\n\\n**Date:** December 3, 2024\\n**Confidence:** 88/100\\n**Novelty:** 75/100\\n**Gene:** EIF4A3 (Eukaryotic Initiation Factor 4A3)\\n**Disease Connection:** Richieri-Costa-Pereira Syndrome (RCPS - rare genetic disorder with microcephaly, craniofacial abnormalities, limb defects), Multiple cancers (bladder, lung, liver, kidney - prognostic marker)\\n\\n## 24. SOD1 Morphological Phenotypes Reveal Novel ALS-Parkinson's Disease Connection Through GBA Similarity\\n\\n**Date:** December 10, 2024\\n**Confidence:** 72/100\\n**Novelty:** 85/100\\n**Gene:** SOD1 (Superoxide Dismutase 1)\\n**Disease Connection:** Amyotrophic Lateral Sclerosis (ALS - 20% of familial cases), Novel connection to Parkinson's Disease through GBA morphological similarity\\n\\n## 25. PHB2 Perturbation Reveals Bidirectional Mitochondrial Dysfunction: Knockout Increases Mitochondrial Mass, Overexpression Causes Catastrophic Depletion\\n\\n**Date:** December 10, 2024\\n**Confidence:** 92/100\\n**Novelty:** 88/100\\n**Gene:** PHB2 (Prohibitin 2)\\n**Disease Connection:** Diabetic Kidney Disease, Cardiorenal Syndrome, Mitochondrial Diseases\\n\\n\\n## 26. PARK2 Knockout Induces ER Stress and Cytoskeletal Remodeling: A Novel Link Between Mitophagy Deficiency and Cellular Architecture\\n\\n**Date:** December 2024\\n**Confidence:** 82/100\\n**Novelty:** 78/100\\n**Gene:** PARK2 (Parkin RBR E3 Ubiquitin Protein Ligase)\\n**Disease Connection:** Parkinson's Disease (autosomal recessive juvenile Parkinsonism, early-onset PD - 50% of familial cases)\\n\\n\\n## 27. C1GALT1 Knockout Induces ER Expansion and Stress: Morphological Signature of O-Glycosylation Deficiency Linking Tn Syndrome to Cancer Progression\\n\\n**Date:** December 10, 2024\\n**Confidence:** 85/100\\n**Novelty:** 88/100\\n**Gene:** C1GALT1 (Core 1 \\u03b21,3-galactosyltransferase 1)\\n**Disease Connection:** Tn Syndrome (rare blood disorder), IgA Nephropathy, Multiple Cancers (colorectal, pancreatic, gastric, breast) - prognostic marker\\n\\n## 28. NLRC5 Knockout Induces Cellular Senescence and Proliferation Defect: A Novel Tumor Suppressor Mechanism Beyond MHC-I Regulation\\n\\n**Date:** December 2024\\n**Confidence:** 85/100\\n**Novelty:** 85/100\\n**Gene:** NLRC5 (NOD-Like Receptor Family CARD Domain Containing 5)\\n**Disease Connection:** Autoimmune diseases (Rheumatoid Arthritis, Inflammatory Bowel Disease), Cancer (Pancreatic adenocarcinoma prognostic marker), Inflammatory disorders\\n\\n## 29. IRF3 Knockout Reveals Paradoxical Mitochondrial Accumulation: A Novel Non-Canonical Function Beyond Apoptosis\\n\\n**Date:** December 10, 2025\\n**Confidence:** 88/100\\n**Novelty:** 85/100\\n**Gene:** IRF3 (Interferon Regulatory Factor 3)\\n**Disease Connection:** Viral infections, Autoimmune diseases (Aicardi-Gouti\\u00e8res syndrome, SAVI), Myocardial infarction, Ischemia-reperfusion injury\\n\\n## 30. DNA Replication Catastrophe: POLA1 Knockout Induces Granular Chromatin and Replication Stress\\n\\n**Date:** December 10, 2025\\n**Confidence:** 92/100\\n**Novelty:** 88/100\\n**Gene:** POLA1 (DNA Polymerase Alpha 1, Catalytic Subunit)\\n**Disease Connection:** X-linked Reticulate Pigmentary Disorder (H02484), Meier-Gorlin Syndrome (H01889), X-linked Syndromic Intellectual Developmental Disorder (H00658), Cancer (liver, lung)\\n\\n## 31. SIRT6 Overexpression Induces Mitochondrial Biogenesis and Metabolic Reprogramming: A Novel Morphological Link to Longevity and Aging\\n\\n**Date:** December 11, 2025\\n**Confidence:** 88/100\\n**Novelty:** 85/100\\n**Gene:** SIRT6 (Sirtuin 6, NAD-dependent protein deacetylase)\\n**Disease Connection:** Aging and cellular senescence, Cardiovascular disease (atherosclerosis, endothelial dysfunction), Metabolic disorders (diabetes, obesity), Cancer (context-dependent tumor suppressor), Neurodegenerative diseases, Osteoarthritis, Intervertebral disc degeneration\\n\\n## 32. RECQL4 Knockout Reveals Novel ER Stress-Proliferation Paradox: Mechanistic Link to Cancer Predisposition in DNA Repair Deficiency Syndromes\\n\\n**Date:** December 11, 2024\\n**Confidence:** 85/100\\n**Novelty:** 90/100\\n**Gene:** RECQL4 (RecQ Like Helicase 4)\\n**Disease Connection:** Rothmund-Thomson Syndrome type 2 (RTS2) - 32% osteosarcoma risk, RAPADILINO Syndrome, Baller-Gerold Syndrome\\n\\n## 33. HSPA5 Knockout Reveals ER Stress-Mediated Mitochondrial Dysfunction and Apoptosis: Morphological Validation of Cancer Therapeutic Target\\n\\n**Date:** December 11, 2025\\n**Confidence:** 82/100\\n**Novelty:** 70/100\\n**Gene:** HSPA5 (Heat Shock Protein Family A Member 5, BiP, GRP78)\\n**Disease Connection:** Multiple cancers (glioblastoma, liver, kidney - unfavorable prognosis), Neurodegeneration (Alzheimer's, Parkinson's, ALS, Huntington's)\\n\\n## 34. VHL Loss Induces Metabolic Reprogramming with Severe Mitochondrial Dysfunction and Cellular Compaction\\n\\n**Date:** December 11, 2025\\n**Confidence:** 88/100\\n**Novelty:** 75/100\\n**Gene:** VHL (Von Hippel-Lindau tumor suppressor)\\n**Disease Connection:** Clear cell renal cell carcinoma (ccRCC - >90% have VHL mutations), Von Hippel-Lindau syndrome, Congenital polycythemia, Malignant paraganglioma\\n\\n## 35. TH Knockout Induces Compensatory Mitochondrial Biogenesis: A Novel Cellular Response to Dopamine Deficiency in Parkinson's Disease\\n\\n**Date:** December 11, 2025\\n**Confidence:** 85/100\\n**Novelty:** 88/100\\n**Gene:** TH (Tyrosine Hydroxylase)\\n**Disease Connection:** Parkinson's Disease (dopaminergic neuron loss), Dopa-responsive dystonia, Segawa syndrome\\n\\n\"]}"}